Screener
Cytek Biosciences, Inc. CTKB Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s operating margin?
- Cytek Biosciences, Inc. (CTKB) reported operating margin of -21.6% in Q2 2026.
- What is the long-term trend for Cytek Biosciences, Inc.'s operating margin?
- Over 4 years (2020 to 2025), Cytek Biosciences, Inc.'s operating margin has grown at a 6.7% compound annual growth rate (CAGR), from 15.5% to -20%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Cytek Biosciences, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude